Zanubrutinib-induced aseptic meningitis: a case report and literature review

• Autori principali: Jinjun Yang (Autore), Lian Wang (Autore), Xiao Zhong (Autore), Chenlu Yang (Autore), Yu Wu (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Zanubrutinib is a Bruton tyrosine kinase (BTK) inhibitor used in B cell malignancy treatment and is generally well tolerated in most patients. Zanubrutinib-induced aseptic meningitis is currently not reported. Herein, we present the first case of zanubrutinib-induced aseptic meningitis. A 33-year-ol...